Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Division of Surgery and Surgical Oncology

Robert Rössle Hospital and Tumor Institute

Max Delbrück Center for Molecular Medicine

Berlin

Germany

Name/email consistency: high

Division of Surgery and Surgical Oncology, Robert Rössle Hospital and Tumor Institute, Max Delbrück Center for Molecular Medicine, Berlin, Germany. 2003
Max Delbrück Center for Molecular Medicine, Virchow Klinikum, Humboldt University, Berlin, Germany. 1998
Division of Surgery and Surgical Oncology Robert-Rössle Hospital, Berlin. 1996

Pentoxifyllin attenuates the systemic inflammatory response induced during isolated limb perfusion with recombinant human tumor necrosis factor-alpha and melphalan. Hohenberger, P., Latz, E., Kettelhack, C., Rezaei, A.H., Schumann, R., Schlag, P.M. Ann. Surg. Oncol. (2003) [Pubmed]
Gastric cancer. Hohenberger, P., Gretschel, S. Lancet (2003) [Pubmed]
Isolated limb perfusion with rhTNF-alpha and melphalan for locally recurrent childhood synovial sarcoma of the limb. Hohenberger, P., Tunn, P.U. J. Pediatr. Hematol. Oncol. (2003) [Pubmed]
Clinical management and current research in isolated limb perfusion for sarcoma and melanoma. Hohenberger, P., Kettelhack, C. Oncology (1998) [Pubmed]
Alteration of tissue oxygen partial pressure during isolated, hyperthermic limb perfusion with cytostatic drugs or recombinant human tumor necrosis factor alpha combined with melphalan. Hohenberger, P., Bida, B., Schlag, P.M. Strahlenther. Onkol (1996) [Pubmed]